Right Ventricular Metrics as End Points in Clinical Trials

Дата публикации: 01-08-2026 00:00:00

This narrative review discusses the current and emerging role of right ventricular–focused imaging and hemodynamic parameters as end points in clinical trials and a comprehensive framework for their development, validation, and broader implementation.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Exercise Performance With Aficamten vs Metoprolol in oHCM	0	6.05	01-08-2026
2	Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk	0	7.22	01-08-2026
3	Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction	0	5.21	08-07-2026
4	Left Ventricular Dimension and Mortality in Patients With Heart Failure	0	3.96	05-08-2026
5	Catheter-Based LAAC vs OAC in Patients With AF	0	13.15	26-08-2026
6	Why Inclusive Clinical Trials Matter	0	10	01-05-2026
7	Cost Offset With Quadruple Therapy for Heart Failure	0	9.43	01-08-2026
8	Cardiac Tamponade Captured in Dual-Phase Computed Tomography	0	9.2	01-08-2026
9	Interpreting the APERITIF Randomized Clinical Trial	0	13.07	01-08-2026
10	Abnormal Echocardiogram in the Setting of Malignancy	0	7.83	01-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.8. Источник: archderm.jamanetwork.com.